From: Factors influencing C-reactive protein status on admission in neonates after birth
CRP<8 mg/L(n = 657) | CRP ≥ 8 mg/L(n = 163) | P-value | |
---|---|---|---|
GA | 35.66 ± 3.11 | 37.71 ± 3.51 | 0.001 |
BW | 2472.00 ± 766.69 | 2987.58 ± 873.21 | 0.001 |
Maternal fever | 0.321 | ||
No | 648 (98.63%) | 159 (97.55%) | |
Yes | 9 (1.37%) | 4 (2.45%) | |
PROM | 0.044 | ||
No | 515 (78.39%) | 116 (71.17%) | |
Yes,<18 h | 59 (8.98%) | 14 (8.59%) | |
Yes,≥18 h | 83 (12.63%) | 33 (20.25%) *# | |
Prenatal antibiotic use | 0.362 | ||
No | 580 (88.28%) | 148 (90.80%) | |
Yes | 77 (11.72%) | 15 (9.20%) | |
Prenatal dexamethasone use | 0.003 | ||
No | 506 (77.02%) | 143 (87.73%) | |
Yes | 151 (22.98%) | 20 (12.27%) | |
Placenta previa | 0.002 | ||
No | 596 (90.72%) | 160 (98.16%) | |
Yes | 61 (9.28%) | 3 (1.84%) | |
Maternal autoimmune diseases | < 0.001 | ||
No | 646 (98.33%) | 151 (92.64%) | |
Yes | 11 (1.67%) | 12 (7.36%) | |
Gestational diabetes | 0.656 | ||
No | 596 (90.72%) | 146 (89.57%) | |
Yes | 61 (9.28%) | 17 (10.43%) | |
Pregnancy hypertension | 0.771 | ||
No | 609 (92.69%) | 150 (92.02%) | |
Yes | 48 (7.31%) | 13 (7.98%) | |
ICP | 0.024 | ||
No | 629 (95.74%) | 162 (99.39%) | |
Yes | 28 (4.26%) | 1 (0.61%) | |
Sex | 0.292 | ||
Male | 365 (55.56%) | 98 (60.12%) | |
Female | 292 (44.44%) | 65 (39.88%) | |
Delivery mode | 0.001 | ||
Vaginal delivery | 145 (22.07%) | 75 (46.01%) | |
Operative vaginal delivery | 7 (1.07%) | 6 (3.68%) | |
Cesarean delivery | 505 (76.86%) | 82 (50.31%) *# | |
Apgar score | 0.235 | ||
8–10 | 528 (80.37%) | 123 (75.46%) | |
4–7 | 111 (16.89%) | 32 (19.63%) | |
0–3 | 18 (2.74%) | 8 (4.91%) | |
MAS | 0.002 | ||
No | 651 (99.09%) | 156 (95.71%) | |
Yes | 6 (0.91%) | 7 (4.29%) | |
NRDS | 0.783 | ||
No | 550 (83.71%) | 135 (82.82%) | |
Yes | 107 (16.29%) | 28 (17.18%) | |
Wet lung of newborn | 0.602 | ||
No | 596 (90.72%) | 150 (92.02%) | |
Yes | 61 (9.28%) | 13 (7.98%) |